These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15883229)

  • 1. Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes.
    Koh KK; Quon MJ; Han SH; Ahn JY; Jin DK; Kim HS; Kim DS; Shin EK
    Hypertension; 2005 Jun; 45(6):1088-93. PubMed ID: 15883229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients.
    Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Seo YH; Kang MH; Ahn TH; Choi IS; Shin EK
    Circulation; 2004 Dec; 110(24):3687-92. PubMed ID: 15569835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes.
    Koh KK; Quon MJ; Han SH; Ahn JY; Lee Y; Shin EK
    Atherosclerosis; 2007 Sep; 194(1):230-7. PubMed ID: 16965776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin combined with ramipril treatment in hypercholesterolemic patients.
    Koh KK; Son JW; Ahn JY; Kim DS; Jin DK; Kim HS; Han SH; Seo YH; Chung WJ; Kang WC; Shin EK
    Hypertension; 2004 Aug; 44(2):180-5. PubMed ID: 15184351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular effects of simvastatin combined with ramipril in hypercholesterolemic patients with coronary artery disease, compared with simvastatin alone: a randomized, double-blind, placebo-controlled, crossover study.
    Koh KK; Son JW; Ahn JY; Jin DK; Kim HS; Kim DS; Han SH; Chung WJ; Park GS; Shin EK
    Atherosclerosis; 2004 Nov; 177(1):147-53. PubMed ID: 15488877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients.
    Han SH; Koh KK; Quon MJ; Lee Y; Shin EK
    Atherosclerosis; 2007 Jan; 190(1):205-11. PubMed ID: 16500662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.
    Lazich I; Sarafidis P; de Guzman E; Patel A; Oliva R; Bakris G
    Diabetes Obes Metab; 2012 Feb; 14(2):181-6. PubMed ID: 21955403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein.
    Abdel-Zaher AO; Elkoussi AE; Abudahab LH; Elbakry MH; Elsayed EA
    Fundam Clin Pharmacol; 2012 Dec; 26(6):701-11. PubMed ID: 21913974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.
    Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Kim JA; Lee Y; Shin EK
    Diabetes Care; 2006 Feb; 29(2):195-201. PubMed ID: 16443859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined statin and angiotensin-converting enzyme (ACE) inhibitor treatment increases the lifespan of long-lived F1 male mice.
    Spindler SR; Mote PL; Flegal JM
    Age (Dordr); 2016 Dec; 38(5-6):379-391. PubMed ID: 27590905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular and metabolic effects of ezetimibe combined with simvastatin in patients with hypercholesterolemia.
    Koh KK; Oh PC; Sakuma I; Kim EY; Lee Y; Hayashi T; Han SH; Park YM; Shin EK
    Int J Cardiol; 2015 Nov; 199():126-31. PubMed ID: 26188833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients.
    Koh KK; Quon MJ; Lee Y; Han SH; Ahn JY; Chung WJ; Kim JA; Shin EK
    Eur Heart J; 2007 Jun; 28(12):1440-7. PubMed ID: 17483542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes.
    Bellia A; Rizza S; Galli A; Fabiano R; Donadel G; Lombardo MF; Cardillo C; Sbraccia P; Tesauro M; Lauro D
    Atherosclerosis; 2010 May; 210(1):199-201. PubMed ID: 20018286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia.
    Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Seo YH; Choi IS; Shin EK
    J Am Coll Cardiol; 2005 May; 45(10):1649-53. PubMed ID: 15893182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.
    Koh KK; Lim S; Choi H; Lee Y; Han SH; Lee K; Oh PC; Sakuma I; Shin EK; Quon MJ
    Diabetes; 2013 Oct; 62(10):3547-52. PubMed ID: 23863812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin and fibrate combination does not additionally lower plasma cholesteryl ester transfer in type 2 diabetes mellitus.
    de Vries R; Dikkeschei BD; Sluiter WJ; Dallinga-Thie GM; van Tol A; Dullaart RP
    Clin Lab; 2012; 58(11-12):1231-9. PubMed ID: 23289194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive beneficial effects of atorvastatin combined with amlodipine in patients with mild-to-moderate hypertension.
    Koh KK; Quon MJ; Han SH; Lee Y; Park JB; Kim SJ; Koh Y; Shin EK
    Int J Cardiol; 2011 Feb; 146(3):319-25. PubMed ID: 19651449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.
    Koh KK; Quon MJ; Han SH; Lee Y; Kim SJ; Park JB; Shin EK
    Atherosclerosis; 2009 Jun; 204(2):483-90. PubMed ID: 18977478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus.
    Hernandez TL; Capell WH; Wolfe P; Gerard LA; Eckel RH
    Am J Cardiol; 2006 Dec; 98(12):1656-9. PubMed ID: 17145229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.